by GlobeNewsWire | Sep 13, 2016 | Globe Newswire
Brooklyn, NY, Sept. 13, 2016 (GLOBE NEWSWIRE) — The first section of the report presents an overview of induced pluripotent stem cells. This section encapsulates the specifications, definition, and classification of induced pluripotent stem cells. Pluripotent...
by GlobeNewsWire | Sep 12, 2016 | Globe Newswire
GAINESVILLE, Fla., and CAMBRIDGE, Mass., Sept. 12, 2016 (GLOBE NEWSWIRE) — Applied Genetic Technologies Corporation (NASDAQ:AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of...
by GlobeNewsWire | Sep 8, 2016 | Globe Newswire
EXTON, Pa., Sept. 08, 2016 (GLOBE NEWSWIRE) — Fibrocell Science, Inc. (NASDAQ:FCSC) today reported the receipt of $18.1 million of gross proceeds from the sale of convertible promissory notes and warrants in its previously announced private placement financing....
by GlobeNewsWire | Sep 8, 2016 | Globe Newswire
CHICAGO, Sept. 08, 2016 (GLOBE NEWSWIRE) — AveXis, Inc. (NASDAQ:AVXS) today announced the pricing of an underwritten public offering of 4,250,000 shares of its common stock, 3,960,145 shares of which are being offered by AveXis and 289,855 shares of which are...
by GlobeNewsWire | Sep 8, 2016 | Globe Newswire
SAN DIEGO, Sept. 08, 2016 (GLOBE NEWSWIRE) — Poseida Therapeutics, Inc. (“Poseida”), a San Diego-based company translating best-in-class gene editing technologies into lifesaving therapeutics, announced the creation of the company’s scientific advisory...